4/23/2010

Vical said stem cell transplant patients who received its cytomegalovirus vaccine TransVax exhibited a continuous increase in cellular and antibody response during a midstage test. The vaccine is designed to prevent the cytomegalovirus from causing transplant rejection.

Related Summaries